Nearly half of all adults who seek help for addiction also meet the clinical criteria for at least one mental health condition. That overlap is not a coincidence, and understanding what is a co-occurring disorder is the first step toward getting treatment that actually works.
What Is a Co-Occurring Disorder?
A co-occurring disorder exists when a person lives with a substance use disorder and at least one mental health condition at the same time. Both diagnoses are present, both are real, and neither one is simply a symptom of the other. They coexist, often feeding into each other in ways that make both harder to manage without addressing them together.
The term itself replaced older, more fragmented language in clinical settings. You may hear it alongside “dual diagnosis” and “comorbidity,” terms that point to the same basic reality but carry slightly different connotations depending on where they’re used.
How This Differs From Dual Diagnosis
“Dual diagnosis” is an older clinical term that became widely used in psychiatric and addiction medicine during the 1980s and 1990s. It means the same thing as co-occurring disorder: two diagnoses present at the same time. The difference is mostly about context. Dual diagnosis still appears frequently in hospital and inpatient settings, insurance documentation, and older research literature. Co-occurring disorder has become the preferred term in behavioral health and outpatient settings because it avoids the implication that one diagnosis is primary and the other secondary. When you’re navigating treatment systems, knowing both terms helps. A program that calls itself a “dual diagnosis” program and one that uses “co-occurring disorder” language are describing the same integrated approach.
How Common Are Co-Occurring Disorders?
According to the National Institute on Drug Abuse (NIDA), more than half of people with a substance use disorder also have a diagnosable mental health condition, and nearly half of people with a serious mental illness meet criteria for a substance use disorder at some point in their lives. SAMHSA’s 2022 National Survey on Drug Use and Health found that approximately 21.5 million adults in the United States had both a substance use disorder and a mental illness in the past year.
Put plainly: if you’re dealing with both, you are not an unusual case. You’re in the majority of people who seek treatment for addiction.
That framing matters clinically. Shame and self-blame are among the most common reasons people delay getting help, and the delay makes both conditions harder to treat. Understanding that co-occurring disorders are the norm in addiction treatment, not the exception, removes a layer of stigma that often keeps people stuck. If you want to recognize early signs that both conditions may be at work, that awareness is worth developing before a formal assessment.
Why Substance Use and Mental Health Conditions Appear Together
This is the part most people don’t fully understand, and it’s the most important mechanism to grasp. Co-occurrence isn’t random. NIDA identifies three distinct pathways that explain why substance use disorders and mental health conditions so frequently show up together.
Self-Medication: When Mental Health Drives Substance Use
The self-medication hypothesis holds that people turn to substances to manage symptoms of an untreated mental health condition. A 2017 study published in the Journal of Affective Disorders, drawing on data from over 43,000 adults in the National Epidemiologic Survey on Alcohol and Related Conditions, found that individuals with anxiety disorders were significantly more likely to report using alcohol and other substances to reduce fear and worry. Depression, trauma responses, and untreated psychosis follow the same pattern.
What this means in practice: alcohol quiets racing thoughts temporarily, opioids blunt emotional pain, stimulants can lift a depressive fog short-term. The relief is real, which is why the behavior reinforces itself. But when the underlying mental health condition goes untreated, the substance becomes the only available coping tool. Stopping the substance without addressing what drove someone to it in the first place leaves a gap that’s almost impossible to sustain. This is one of the clearest reasons treating addiction without addressing mental health so often leads to relapse.
Substance Use That Triggers Mental Health Conditions
The pathway also runs in the opposite direction. Prolonged substance use alters brain chemistry in ways that can precipitate or worsen depression, anxiety, and in some cases psychosis. A 2018 meta-analysis published in Psychological Medicine, examining data across 35 longitudinal studies, confirmed that heavy cannabis use is associated with a significantly elevated risk of developing a psychotic disorder, particularly in individuals with a genetic predisposition.
Alcohol is a depressant at the neurological level. Regular heavy use suppresses serotonin and dopamine regulation over time, which means it can cause or deepen depressive episodes independent of any pre-existing condition. This is why detox alone rarely resolves mental health symptoms. The brain needs time and targeted treatment to recalibrate, and for many people, psychiatric symptoms that appear during or after substance use require their own clinical management.
Shared Brain and Genetic Risk Factors
The third pathway is biological predisposition. A 2008 study from the National Institute on Alcohol Abuse and Alcoholism, examining data from over 8,000 twin pairs, found that genetic factors account for 40 to 60 percent of the risk for both alcohol use disorder and major depression, and that a portion of that genetic risk is shared. More recent neuroimaging research has identified overlapping abnormalities in prefrontal cortex function, dopamine signaling, and stress-response systems in people with both substance use disorders and conditions like PTSD or ADHD.
The takeaway: some people are neurobiologically predisposed to both. That is not a character flaw or a failure of willpower. It is biology, and integrated treatment addresses it at the biological level through a combination of medication, therapy, and structured support.
The Most Common Co-Occurring Disorder Combinations
Certain pairings appear far more often than others in both clinical practice and research literature. These are the combinations worth knowing by name.
Depression and Alcohol or Substance Use
Depression and alcohol use disorder are among the most common co-occurring pairings in treatment settings. According to a study published in JAMA Psychiatry drawing on the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III, 2012-2013, n=36,309), approximately 40 percent of individuals with alcohol use disorder also met criteria for major depression.
The mechanism is straightforward: alcohol is a central nervous system depressant. Short-term, it can reduce inhibitions and create a temporary sense of relief from low mood. Over time, regular use disrupts sleep architecture, depletes serotonin production, and worsens the neurological underpinnings of depression. People often describe drinking more as their depression worsens and feeling more depressed as their drinking increases. Understanding the reinforcing cycle between depression and alcohol is often the turning point where people recognize they need treatment for both, not just one.
PTSD and Substance Use Disorders
PTSD and substance use disorders have a well-documented co-occurrence, particularly among combat veterans, survivors of sexual trauma, and individuals with histories of childhood abuse. A 2013 study published in Drug and Alcohol Dependence, examining 2,372 veterans returning from Iraq and Afghanistan, found that 63 percent of those who screened positive for PTSD also met criteria for a substance use disorder.
The mechanism is avoidance. Substances blunt hyperarousal, reduce the frequency of intrusive memories short-term, and create a temporary state of emotional numbing that functions as relief for people with PTSD symptoms. The problem is that avoidance is one of the core maintaining factors of PTSD. Every time a substance is used to escape a trigger rather than process it, the trauma response is reinforced. The relationship between PTSD and addiction is one of the most studied co-occurring pairings precisely because it illustrates this cycle so clearly.
Anxiety Disorders and Substance Use
Generalized anxiety disorder, panic disorder, and social anxiety disorder all co-occur frequently with alcohol and benzodiazepine misuse. A 2013 review in Expert Review of Neurotherapeutics found that approximately 20 percent of people with social anxiety disorder also met criteria for alcohol use disorder, with alcohol most commonly used to reduce social inhibition before anxiety-provoking situations.
The clinical concern here is tolerance. Alcohol and benzodiazepines reduce anxiety quickly and reliably in the short term, which makes them highly reinforcing for someone with a diagnosed or undiagnosed anxiety disorder. But both substances produce physical dependence and tolerance, meaning more is needed over time to produce the same calming effect. Anxiety that persists or intensifies after stopping substance use is a strong signal of an independent anxiety condition that requires its own treatment. Understanding how anxiety can drive someone toward substances in the first place is a useful starting point for that conversation.
ADHD and Substance Use Disorders
Adult ADHD is significantly underdiagnosed, and that diagnostic gap carries real consequences. A 2014 meta-analysis published in JAMA Psychiatry, reviewing data from 83 studies and over 148,000 participants, found that adults with ADHD were approximately 2.5 times more likely to develop a substance use disorder than adults without ADHD. Stimulant misuse and alcohol use disorder are the most common pairings.
The mechanism involves both self-medication and impulsivity. Stimulants can temporarily improve focus and executive function in someone with unmanaged ADHD, creating a reinforcing pattern of misuse. Impulsivity, a core ADHD symptom, also lowers the threshold for substance use generally. Untreated ADHD is a recognized relapse risk factor, which is exactly why comprehensive screening during a dual-diagnosis assessment matters. The connection between ADHD and substance use disorder often only becomes clear once someone is asked the right questions.
Why Co-Occurring Disorders Are Frequently Missed
Diagnosing co-occurring disorders is genuinely difficult, and missed diagnoses are common. The core problem is symptom overlap: substance use can produce symptoms that look like depression, anxiety, or psychosis, and those same conditions can be mistaken for intoxication or withdrawal.
A 2016 study in Psychiatric Services, examining data from 1,200 adults in community mental health settings, found that fewer than half of individuals with co-occurring disorders received treatment that addressed both conditions. The diagnostic error usually goes in one direction: the substance use disorder gets identified, but the mental health condition is attributed to the substance use and not assessed independently.
If you’ve been treated for one condition without the other being identified or addressed, that gap is worth raising directly with a clinician. Asking specifically for a comprehensive dual-diagnosis assessment, not just a standard intake screen, is the practical step that matters here.
What Integrated Treatment Looks Like , and Why It Works Better
For decades, the standard approach was sequential treatment: stabilize from addiction first, then address mental health. Research has consistently shown that this model produces worse outcomes than integrated care, where both conditions are treated simultaneously by a coordinated team.
A 2019 Cochrane Review of 41 randomized controlled trials found that integrated treatment for co-occurring disorders produced better substance use outcomes, better mental health outcomes, and higher rates of treatment retention compared to sequential or parallel models of care. The mechanism is not complicated: when mental health symptoms are left untreated during addiction treatment, they become the primary driver of relapse. Understanding how co-occurring disorders shape treatment results explains why the structure of a program matters as much as whether someone participates in it.
When evaluating a treatment program, the most direct question to ask is whether mental health and substance use are addressed by the same clinical team in the same treatment plan, or whether they’re managed in separate silos that don’t communicate.
The Role of Medication in Co-Occurring Disorder Treatment
Medication plays a direct clinical role in integrated treatment, and dismissing it as optional or secondary is a mistake. For opioid use disorder with co-occurring depression, for example, buprenorphine or methadone as medication-assisted treatment (MAT) can stabilize cravings and withdrawal while antidepressant therapy simultaneously addresses the depressive disorder. A 2020 study in JAMA Network Open, examining outcomes for 38,000 patients with opioid use disorder, found that those who received both MAT and a psychiatric medication had significantly lower rates of overdose and treatment dropout than those who received either alone.
Medication in this context is not a crutch. It addresses biological factors in co-occurring disorders the same way insulin addresses diabetes or antihypertensives address high blood pressure. It reduces the physiological noise so that therapy can do its work.
Therapy Approaches That Address Both Conditions
The therapies most commonly used in integrated treatment include Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and trauma-focused approaches like Eye Movement Desensitization and Reprocessing (EMDR) and Cognitive Processing Therapy (CPT). A 2017 meta-analysis in Clinical Psychology Review, examining 37 randomized controlled trials, found that CBT-based interventions produced significant improvements in both substance use and depression outcomes when both were targeted in the same treatment protocol.
DBT is particularly relevant for individuals with emotional dysregulation alongside addiction, where impulsive behavior and mood instability are central features of the clinical picture. When evaluating a program, ask specifically which modalities are used, and whether the clinicians delivering them are trained in both addiction treatment and mental health, not one or the other.
What to Try This Week
If anything in this article felt personally recognizable, the specific move is this: request a comprehensive dual-diagnosis assessment from a licensed clinician. Not a general intake screen. A full assessment includes a structured clinical interview that evaluates both substance use history and psychiatric symptoms independently, uses validated screening tools for both domains, and produces a diagnosis that accounts for both conditions simultaneously. That distinction matters because a standard intake screen will often identify the substance use and attribute mood or anxiety symptoms to it, missing the independent mental health condition entirely. You can ask for it by name and describe exactly what you’re looking for: a simultaneous evaluation of both substance use and mental health that doesn’t treat one as the cause of the other.
Frequently Asked Questions
Can someone have more than one mental health condition alongside a substance use disorder?
Yes. Having multiple co-occurring mental health conditions alongside a substance use disorder is clinically common, not unusual. For example, someone might live with PTSD, generalized anxiety disorder, and alcohol use disorder simultaneously. Each condition requires its own assessment and inclusion in the treatment plan, which is why comprehensive intake evaluations matter.
Does a co-occurring disorder mean the mental health condition caused the addiction?
Not necessarily. A co-occurring disorder means both conditions exist at the same time. The mental health condition may have preceded substance use, may have developed as a result of it, or both may share overlapping genetic and neurobiological risk factors. Causality is not required for diagnosis, and integrated treatment addresses both regardless of which came first.
Is it possible to recover from both conditions at the same time?
Yes, and integrated treatment is specifically designed to make that possible. Research consistently shows that treating both conditions simultaneously produces better outcomes than sequential treatment. Recovery from one condition without the other is harder to maintain, which is why the structure of treatment matters as much as participation in it.
How do I know if I have a co-occurring disorder?
A formal dual-diagnosis assessment performed by a licensed clinician is the only way to confirm a co-occurring disorder. Signs that warrant asking for one include persistent mental health symptoms that continue during periods of sobriety, a history of using substances to manage emotional pain or anxiety, and previous treatment that addressed only one condition without lasting results.
Will stopping substance use resolve the mental health symptoms?
Sometimes, but not reliably. Some symptoms resolve after a period of abstinence as the brain chemistry stabilizes. Others persist independently and require their own treatment. Anxiety, depression, or trauma-related symptoms that remain present several weeks into sobriety are strong indicators of a separate mental health condition that needs clinical attention beyond addiction treatment alone.